Press release
Increasing Aging Population Drives Demand For Biosimilar Therapeutic Peptides In Chronic Disease Management: A Significant Driver Propelling The Biosimilar Therapeutic Peptides Market In 2025
The Biosimilar Therapeutic Peptides Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].How Big Is the Biosimilar Therapeutic Peptides Market Size Expected to Be by 2034?
The biosimilar therapeutic peptides market size has grown exponentially in recent years. It will grow from $2.06 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 30.3%. This rapid growth is attributed to the increasing demand for cost-effective therapeutics, supportive regulatory frameworks, patent expirations of biologic drugs, the rising prevalence of chronic diseases, and well-established manufacturing processes for biosimilars.
The biosimilar therapeutic peptides market is expected to grow rapidly to $4.87 billion in 2029 at a CAGR of 16.1%. This is fueled by broader treatment applications, global aging, competitive market dynamics, alliances, and patient demand for non-invasive options. Notable trends include biotech innovation, higher biologic demand, efficient production methods, affordability focus, and technological improvements.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3423
What Are the Emerging Segments Within the Biosimilar Therapeutic Peptides Market?
The biosimilar therapeutic peptides market covered in this report is segmented -
1) By Type: Innovative, Generic
2) By Route Of Administration: Parenteral Route, Transdermal Route, Other Route Of Administrations
3) By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders
Subsegments:
1) By Innovative: Long-Acting Peptides, Combination Peptides
2) By Generic: Monoclonal Antibodies, Hormones, Enzymes
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp
What Long-Term Drivers Are Shaping Biosimilar Therapeutic Peptides Market Trends?
The increasing aging population is expected to lead to more cases of chronic diseases, thereby contributing to the growth of the biosimilar therapeutic peptides market. Elderly individuals are more susceptible to chronic conditions, and the global population over 60 is predicted to reach 2 billion by 2050, according to the World Health Organization. The growing demand for treatments for chronic diseases and cancers among the aging population is expected to drive the biosimilar therapeutic peptide market.
Who Are the Top Competitors in Key Biosimilar Therapeutic Peptides Market Segments?
Major companies operating in the biosimilar therapeutic peptides market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceuticals Co. Ltd., Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, BioXpress Therapeutics SA, Apotex Inc., Teva Pharmaceuticals Industries Ltd., Sandoz International GmbH, Lonza Inc., Stada Arzneimittel AG, Ipsen S.A, Biocon Biopharmaceuticals Pvt. Ltd., Dr. Reddy's Laboratories Ltd., Alvogen Pharma US Inc., Corden Pharma GmbH, Bachem Holding AG, PolyPeptide Laboratories Ltd., PeptiDream Inc., Coherus BioSciences Inc., Celltrion Inc., BioPartners Inc., Samsung Bioepis Co. Ltd.
What Trends Are Expected to Dominate the Biosimilar Therapeutic Peptides Market in the Next 5 Years?
Companies in the biosimilar therapeutic peptide market are developing research platforms to optimize peptide synthesis, enhance production efficiency, and ensure consistent quality throughout the discovery and commercialization phases. The Biodrug Design Accelerator platform is designed to manage research processes in peptide drug discovery, which is a promising field for new drug development. For example, in May 2023, Fujitsu Limited, a US-based company, launched the Biodrug Design Accelerator platform to help accelerate peptide drug discovery, improving efficiency and facilitating communication between scientists during the drug development process.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report
Which Regions Are Becoming Hubs for Biosimilar Therapeutic Peptides Market Innovation?
The countries covered in the biosimilar therapeutic peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Biosimilar Therapeutic Peptides Market?
2. What is the CAGR expected in the Biosimilar Therapeutic Peptides Market?
3. What Are the Key Innovations Transforming the Biosimilar Therapeutic Peptides Industry?
4. Which Region Is Leading the Biosimilar Therapeutic Peptides Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Aging Population Drives Demand For Biosimilar Therapeutic Peptides In Chronic Disease Management: A Significant Driver Propelling The Biosimilar Therapeutic Peptides Market In 2025 here
News-ID: 4056939 • Views: …
More Releases from The Business Research Company
Leading Companies Solidify Their Presence in the Silicone Structural Glazing Mar …
The silicone structural glazing market is positioned for significant expansion in the coming years, driven by advances in building technology and increased environmental awareness. This sector is evolving rapidly as demand grows for more energy-efficient and aesthetically appealing architectural solutions. Let's explore the market's current size, key players, emerging trends, and the main segments that are shaping its future.
Silicone Structural Glazing Market Value Forecast Through 2030
The market for silicone…
Future Prospects: Key Trends Shaping the Self-Healing Concrete Market up to 2030
The self-healing concrete market is capturing significant attention as innovations and sustainability demands rise in construction. This sector is set to experience remarkable growth due to advancements in materials and technology, shaping the future of durable and intelligent infrastructure solutions. Let's explore the market's size, key players, emerging trends, and segment outlook to understand its trajectory.
Projected Market Size and Growth Prospects for the Self-Healing Concrete Market
The self-healing concrete market…
Analysis of Key Market Segments Driving the ROS-Based Robot Industry
The ROS-based robot market is positioned for substantial growth as robotics technology continues to advance rapidly. With increasing innovation in software, hardware, and AI integration, this sector is set to transform multiple industries by 2030. Below, we explore the market's future size, leading companies, key trends, and segmentation details to understand its evolving landscape.
Projected Market Size and Expansion of the ROS-Based Robot Market
The ROS-based robot market is anticipated to…
Global Trends Overview: The Rapid Evolution of the Robotic Panelized Home Builde …
The robotic panelized home builder market is positioned for impressive growth in the coming years as automation and robotics increasingly transform construction processes. Driven by technological advancements and expanding prefab housing projects, this market is set to reshape how homes are built with greater speed and efficiency. Let's explore the market's size, leading companies, emerging trends, and key segments that are shaping its future.
Strong Growth Forecast for the Robotic Panelized…
More Releases for Peptides
Impact Of Rising Infectious Diseases On Antimicrobial Peptides: A Key Driver Pow …
The Anti Microbial Peptides Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Anti Microbial Peptides Market Size and Its Estimated Growth Rate?
In the past years, there has been significant growth in the anti microbial peptides market size. It is anticipated to…
Applications of Peptides: Unlocking Their Potential
Peptides [https://www.sctsgroup.com/custom-peptide/] are short chains of amino acids that have attracted widespread attention in various fields due to their wide range of applications. Applications of peptides span pharmaceuticals, cosmetics and nutraceuticals, demonstrating their multifaceted benefits. As research continues to develop, the potential of peptides is increasingly recognized.
In the medical field, peptides have particularly promising applications. They are used in drug development, where specific peptides can target disease mechanisms with high…
Antimicrobial Peptides Beyond Traditional Antibiotics: The Antimicrobial Peptide …
Antimicrobial Peptides Market worth $532.02 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Peptides Market - (By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments (Pneumonia, Hepatitis, Bacterial infections, HIV), By Route of Administration (Topical, Subcutaneous, Intravenous), By End User (Pharma and Healthcare, Agriculture Industry,…
What Is The Benefit Of Collagen Peptides?
Who would've guessed that something from bones and skin would become a must-have supplement? We are talking about Collagen. Collagen is being used as powder and capsules as well, or if you are a fan of Organic ways, you can try Bone Broths. It's a protein that works inside your body, and it naturally creates itself inside. The main function of this Collagen in your body is to help your…
Collagen Peptides Market Size And Share
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Collagen Peptides Market was valued at USD 859.24 Million in 2019 and is projected to reach USD 2019.01 Million by 2027, growing at a CAGR of 11.29% from 2020 to 2027.
The collagen peptides market is experiencing robust growth, driven by several key factors. A significant driver is the rising consumer awareness regarding health and wellness, leading to increased demand for dietary supplements and functional foods enriched with…
Peptides Market Current Scenario and Future Prospects
The Peptides Market study with 65+ market data Tables, Pie charts & Figures is now released by HTF MI. The research assessment of the Market is designed to analyze futuristic trends, growth factors, industry opinions, and industry-validated market facts to forecast till 2029. The market Study is segmented by key a region that is accelerating the marketization. This section also provides the scope of different segments and applications that can…
